Gregory Gene Freitag - 26 May 2021 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/Gregory Freitag
Issuer symbol
AXGN
Transactions as of
26 May 2021
Net transactions value
$0
Form type
4
Filing time
28 May 2021, 16:05:58 UTC
Next filing
03 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $84,241 +22,954 +10% $3.67 251,306 26 May 2021 Direct
transaction AXGN Common Stock Options Exercise $45,810 +9,000 +3.6% $5.09 260,306 26 May 2021 Direct
transaction AXGN Common Stock Options Exercise $32,700 +6,000 +2.3% $5.45 266,306 26 May 2021 Direct
transaction AXGN Common Stock Options Exercise $81,750 +15,000 +5.6% $5.45 281,306 26 May 2021 Direct
transaction AXGN Common Stock Options Exercise $447,500 +50,000 +18% $8.95 331,306 26 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Employee Stock Option (right to purchase) Options Exercise $84,241 -22,954 -100% $3.67 0 26 May 2021 Common Stock 22,954 $3.67 Direct F1
transaction AXGN Employee Stock Option (right to purchase) Options Exercise $45,810 -9,000 -100% $5.09 0 26 May 2021 Common Stock 9,000 $5.09 Direct F2
transaction AXGN Employee Stock Option (right to purchase) Options Exercise $32,700 -6,000 -100% $5.45 0 26 May 2021 Common Stock 6,000 $5.45 Direct F3
transaction AXGN Stock Option (right to purchase) Options Exercise $81,750 -15,000 -100% $5.45 0 26 May 2021 Common Stock 15,000 $5.45 Direct F4
transaction AXGN Employee Stock Option (right to purchase) Options Exercise $447,500 -50,000 -100% $8.95 0 26 May 2021 Common Stock 50,000 $8.95 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.
F2 All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2019 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2016 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.
F3 All shares of Common Stock underlying the employee stock option became fully vested on May 26, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on May 26, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.
F4 All shares of Common Stock underlying the employee stock option became fully vested on December 31, 2016. The option vested in two equal installments beginning on September 30, 2016, and became fully vested on December 31, 2016.
F5 All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.